Clinical Trial

Periprosthetic Joint Infections: Diagnostic Accuracy and Cost-effectiveness Analysis of Serum and Synovial Markers

Study acronym: DECISION
Recruiting
View on ClinicalTrials.gov →
Summary
Total joint replacement (TJR) is an increasing effective procedure in orthopedics. However, TJR failure due to aseptic or septic loosening remains an important problem, often due to predisposing factors of the patient, which determine the need to perform a revision surgery. In light of the recent conclusions emerged on the still open problems concerning the diagnostic accuracy of serum and synovial fluid markers in the diagnosis of peri-prosthetic joint infection (PJI), the project aims at evaluating the diagnostic accuracy and cost-effectiveness of the combination of serum and/or synovial markers in the diagnosis of PJI. Through a diagnostic clinical study on patients hospitalized for revision surgery the project would provide evidences on the potentiality of the combination of some markers in accelerating the PJI diagnosis for the best selection of surgical strategy, choosing the suitable cutoff thresholds to mitigate the effect of some factors on markers' discriminatory capability.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-04-22; most recent amendment 2025-09-19.
Status change: Not Yet Recruiting → Recruiting 2022-03-21
Trial Details
NCT Number NCT04858217
Lead Sponsor Istituto Ortopedico Rizzoli
Collaborators: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Prosthetic Joint Infection
Enrollment 270 participants
Start Date 2022-02-01
Primary Completion 2025-06-17 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-22